MOTS-C 10mg
$79.00
This product is intended for research and medical purposes only, to be used by trained professionals.
Research has suggested MOTS-c is an exercise mimetic, a 16-amino-acid peptide that is encoded in the mitochondrial genome of cells. According to clinical studies, it improves insulin sensitivity. While the study is still ongoing, control group examinations using diet-induced obese mice have shown improvements in insulin sensitivity. Researchers are still studying to see if the MOTS-c changes plasma markers, which are used to determine the body’s metabolic condition.
Research has shown that it targets body muscles and regulates its metabolism using the folate-purine-AMPK pathway. By doing so, it becomes effective protection against obesity and insulin resistance that stems from the diet that one is taking or age.
HOW MOTS-C PEPTIDE REGULATES GLUCOSE
Clinical studies have shown that MOTS-c promotes the production of endogen AMP analogue AICAR, which in turn, helps in the synthesis of AMP-activated protein kinase [1] (also referred to as AMPK). Before the production of AMPK, its cellular actions inhibit the folate cycle along with de novo purine biosynthesis. The AMPK then induces systemic cellular uptake of glucose and enhances insulin sensitivity. These studies suggest the mitochondria [2] offer active regulation of metabolic homeostasis via this peptide encoded in their genome.
Research has confirmed that the peptide genome can help reduce insulin resistance [3]. Health experts recommend taking the medication along with a strict, balanced diet to lower the amount of fat taken to manage obesity. Other studies have shown that general weight gain may increase insulin insensitivity, especially on diabetes type 1 patients. Cutting down the fat intake and increased levels of MOTS-c may lower the diet-induced metabolic dysfunction and associated inflammation.
References:
[1] https://physoc.onlinelibrary.wiley.com/doi/full/10.14814/phy2.14171
- Buy 5 and save 10%
- Buy 10 and save 15%
Legal Notice Regarding This Product
THIS PRODUCT IS STRICTLY INTENDED FOR RESEARCH USE ONLY. It is designated solely as a research chemical. Usage is confined to in vitro testing and laboratory experimentation exclusively. Information available on our website about this product is for educational purposes only and should not be interpreted as an endorsement or directive for use outside these bounds. Introducing this product into humans or animals by any route is strictly prohibited by law. Handling of this product should be undertaken only by licensed, qualified professionals.
This product is not to be used as a drug, food, or cosmetic. Misbranding, misusing, or mislabeling this product as a drug, food, or cosmetic is illegal. Users are responsible for complying with all applicable laws and regulations regarding the handling and use of this product.
Batch:BP3495C
| Dates |
19 June 24
Avg Mass:
10mg
|
|---|---|
| Janoshik Lab Results |
10.26mg
Full Report:
|
| MZ Biolabs Lab Results | 99.494% |
THE PRODUCTS PURCHASED ON THIS WEBSITE ARE INTENDED FOR RESEARCH CHEMICAL USE ONLY. These products are not intended to be used for human or animal consumption and/or ingestion of any kind. These products should not be used as food additives, drugs or household chemicals. These products should only be used by Qualified Professionals.
Bodily introduction into Human and Animals of any kind is strictly forbidden by law.
All the product information on this website is for educational purpose only.
MOTS-C is intended for research and medical purposes only, to be used by trained professionals.
Research has suggested MOTS-c is an exercise mimetic, a 16-amino-acid peptide that is encoded in the mitochondrial genome of cells. According to clinical studies, it improves insulin sensitivity. While the study is still ongoing, control group examinations using diet-induced obese mice have shown improvements in insulin sensitivity. Researchers are still studying to see if the MOTS-c changes plasma markers, which are used to determine the body’s metabolic condition.
Research has shown that MOTS-C targets body muscles and regulates its metabolism using the folate-purine-AMPK pathway. By doing so, it becomes effective protection against obesity and insulin resistance that stems from the diet that one is taking or age.
HOW MOTS-C PEPTIDE REGULATES GLUCOSE
Clinical studies have shown that MOTS-c promotes the production of endogen AMP analogue AICAR, which in turn, helps in the synthesis of AMP-activated protein kinase [1] (also referred to as AMPK). Before the production of AMPK, its cellular actions inhibit the folate cycle along with de novo purine biosynthesis. The AMPK then induces systemic cellular uptake of glucose and enhances insulin sensitivity. These studies suggest the mitochondria [2] offer active regulation of metabolic homeostasis via this peptide encoded in their genome.
Research has confirmed that the peptide genome can help reduce insulin resistance [3]. Health experts recommend taking the medication along with a strict, balanced diet to lower the amount of fat taken to manage obesity. Other studies have shown that general weight gain may increase insulin insensitivity, especially on diabetes type 1 patients. Cutting down the fat intake and increased levels of MOTS-c may lower the diet-induced metabolic dysfunction and associated inflammation.
References:
[1] https://physoc.onlinelibrary.wiley.com/doi/full/10.14814/phy2.14171
MOTS-C 10mg
$79.00
